Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities | CDC RFA GH20 2083

Opportunity Information: Apply for CDC RFA GH20 2083

The grant opportunity "Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities" (Funding Opportunity Number CDC RFA GH20 2083) is a CDC cooperative agreement aimed at lowering the impact of specific parasitic diseases in the U.S. through practical, real-world public health work rather than purely academic research. It is administered by the Department of Health and Human Services, Centers for Disease Control and Prevention, within the Center for Global Health, continuing efforts led by the Division of Parasitic Diseases and Malaria to improve how parasitic infections are recognized, prevented, and managed in U.S. communities and clinical settings.

The program is organized around two distinct components that target different infections and require different types of interventions: Chagas disease and soil-transmitted helminths. Across both components, the CDC emphasizes evidence-based strategies that can deliver meaningful public health results, reach large portions of populations at risk, and show strong potential for population-level impact. The overall intent is to strengthen identification of infection, expand appropriate testing and treatment, and improve prevention and control practices through tools that public health programs and healthcare providers can actually use.

The Chagas disease component focuses on improving diagnosis and management in the United States by building on existing data sources. The central activities revolve around developing and disseminating practical strategies and guidance for clinicians and public health partners, including educational tools, materials, and guidelines related to Chagas disease testing, clinical management, and best practices. A major theme is closing knowledge and practice gaps among healthcare providers so that more patients who have, or are at risk for, infection with the parasite that causes Chagas disease are appropriately identified, tested, and managed. In practical terms, this component prioritizes boosting provider awareness, standardizing and spreading best practices, improving the availability and use of training resources, and increasing appropriate testing and follow-up care so that infections are not missed and patients can be connected to treatment and monitoring.

The soil-transmitted helminths component is framed more as direct, on-the-ground disease control work supported by ongoing congressional funding. It targets historically endemic areas of Alabama and Mississippi and supports public health practice activities to investigate and address infections with soil-transmitted helminths. The funded approach centers on field-oriented interventions such as testing to identify infections, treatment to reduce disease burden, and health education to help prevent reinfection and reduce transmission risks. This part of the opportunity is aimed at implementing and strengthening control activities in specific U.S. regions where these infections have been documented historically, with an emphasis on practical interventions that can be carried out in partnership with affected communities.

Administratively, this is a discretionary funding opportunity using a cooperative agreement model, meaning recipients should expect substantial involvement and collaboration with CDC during planning, implementation, and evaluation. The estimated award ceiling is $1,000,000, with an expected total of 7 awards. Eligibility is broad and includes state, county, and local governments; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; public housing authorities; nonprofit organizations (both 501(c)(3) and non-501(c)(3)); for-profit organizations (including small businesses); and other eligible entities as clarified in the notice. The opportunity was posted March 27, 2020, with an original application deadline of May 26, 2020 (11:59 p.m. ET). Overall, the grant is positioned to fund implementers who can translate existing knowledge and data into practical tools and interventions that measurably improve prevention, detection, and management of these parasitic infections in U.S. settings.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.084.
• This funding opportunity was created on Mar 27, 2020.
• Applicants must submit their applications by May 26, 2020 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
• The number of recipients for this funding is limited to 7 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For profit organizations other than small businesses, Small businesses, Others (see text field entitled Additional Information on Eligibility for clarification), Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for CDC RFA GH20 2083

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: